• Profile
Close

Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: A randomized clinical trial

JAMA Oct 16, 2018

Vollesen ALH, et al. – In this randomized, double-blind, placebo-controlled, two-way crossover study, researchers assessed whether calcitonin gene-related peptide (CGRP) induces cluster headache attacks in active-phase episodic cluster headache (ECH), remission-phase ECH, and chronic cluster headache (CCH). They found that CGRP provokes cluster headache attacks in active-phase ECH and CCH but not in remission-phase ECH. Findings suggested that anti-CGRP drugs may be effective in the management of cluster headache.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay